focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 46.05
Bid: 45.00
Ask: 47.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.444%)
Open: 46.05
High: 46.05
Low: 46.05
Prev. Close: 46.05
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of remaining minority interest

17 Feb 2023 07:00

RNS Number : 2196Q
Benchmark Holdings PLC
17 February 2023
 

RNS Reach

17 February 2023

Benchmark Holdings plc

("Benchmark", the Group, or the "Company")

Acquisition of remaining minority interest in Benchmark Genetics Iceland

Benchmark Holdings, the aquaculture biotechnology company, announces that it has acquired the remaining 10.52% minority interest in its subsidiary Benchmark Genetics Iceland. Enhanced by the recent construction of a new incubation centre, Benchmark Genetics Iceland is core to the Company's ability to supply highly specialist, biosecure salmon eggs to salmon producers to c.35 countries around the world, year-round. Benchmark Genetics Iceland represents 50% of the Group's salmon egg capacity.

Background

In December 2014 Benchmark acquired a 89.48% interest in Stofnfiskur, subsequently rebranding it Benchmark Genetics Iceland and merging it with its salmon genetics business in Norway. Since the acquisition, the business has grown substantially, benefitting from Benchmark's leading market position, investment and knowledge transfer within the Group. 

Trond Williksen commented:

"Benchmark's genetics operations in Iceland have a 200m egg capacity and are core to our ability to supply highly biosecure salmon eggs year round to customers around the world. The acquisition of the remaining minority interest is a natural step in delivering shareholder value through full ownership of the success of our genetics business."

Rabobank acted as financial adviser to Benchmark in the transaction.

Enquiries

For further information, please contact:

Benchmark Holdings plc

Tel: 020 3696 0630

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith

 

MHP

Tel: 020 3128 8004

Katie Hunt, Reg Hoare, Veronica Farah

benchmark@mhpgroup.com

 

About Benchmark 

Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare.

Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark serves major aquaculture species - salmon, shrimp, sea bass and bream and tilapia - in main aquaculture regions around the world. Find out more at www.benchmarkplc.com

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRATFMBTMTBBTRJ
Date   Source Headline
19th Feb 202410:59 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
16th Feb 202410:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
15th Feb 20247:00 amRNSQ1 Results
14th Feb 202411:37 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
8th Feb 20244:00 pmRNSResult of AGM
6th Feb 20244:08 pmRNSForm 8.3 - Benchmark Holdings PLC
6th Feb 20247:36 amRNSForm 8.3 - Benchmark Holdings PLC
5th Feb 20245:30 pmRNSRule 2.9 Announcement
5th Feb 20242:50 pmRNSForm 8.3 - Benchmark Holdings PLC
5th Feb 202410:20 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
1st Feb 202410:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
1st Feb 202410:16 amRNSForm 8.3 - Benchmark Holdings plc
31st Jan 20242:03 pmRNSForm 8.3 - Benchmark Holdings
31st Jan 20247:00 amRNSTotal Voting Rights
30th Jan 202411:38 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
29th Jan 202412:18 pmRNSForm 8.3 - Benchmark Holdings plc
26th Jan 20243:19 pmRNSForm 8.3 - Benchmark Holdings Plc - Replacement
26th Jan 202410:48 amRNSForm 8.3 - Benchmark Holdings
26th Jan 20247:00 amRNSForm 8 (OPD) (Benchmark Holdings PLC)
24th Jan 20243:37 pmRNSForm 8.3 - Benchmark Holdings plc - Amendment
24th Jan 20248:46 amRNSForm 8.3 - Benchmark Holdings plc
23rd Jan 20242:40 pmRNSForm 8.3 - Benchmark Holdings Plc
23rd Jan 20242:25 pmRNSForm 8.3 - Benchmark Holdings Plc-Replacement
23rd Jan 20241:57 pmGNWForm 8.3 - [BENCHMARK HOLDINGS PLC - Opening Disclosure - 22 01 2024] - (CGAML)
23rd Jan 202411:20 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
23rd Jan 20247:00 amRNSNotice of Q1 Results
22nd Jan 20246:02 pmRNSRule 2.9 Announcement
22nd Jan 20245:14 pmRNSForm 8.3 - Benchmark Holdings Plc-Replacement
22nd Jan 20244:27 pmRNSForm 8.3 - Benchmark Holdings Plc
22nd Jan 20241:48 pmRNSForm 8.3 -Benchmark Holdings Plc
22nd Jan 20247:00 amRNSStrategic Review and Formal Sale Process
16th Jan 20245:30 pmRNSNotice of AGM - correction
9th Jan 20245:15 pmRNSPosting of Notice of AGM
12th Dec 20235:50 pmRNSNew Long Term Incentive Plan and PDMR Dealing
12th Dec 20231:54 pmRNSDirectorate Change
7th Dec 202312:00 pmRNSPublication of Annual Report and Notice of AGM
29th Nov 20237:01 amRNSDirectorate Change
29th Nov 20237:01 amRNSQ4 Results
29th Nov 20237:00 amRNSFull Year Results
6th Nov 202310:24 amRNSNotice of Q4 and Full Year Results
31st Oct 20237:00 amRNSTotal Voting Rights
10th Oct 202311:26 amRNSNew salmon broodstock licenses - correction
10th Oct 202310:06 amRNSGrant of two new salmon broodstock licenses
29th Sep 20237:00 amRNSTotal Voting Rights
21st Sep 20237:00 amRNSBlock Listing Six Monthly Return
31st Aug 20237:00 amRNSTotal Voting Rights
24th Aug 20237:00 amRNSQ3 Results
11th Aug 20237:00 amRNSNotice of Q3 Results
31st Jul 20237:00 amRNSTotal Voting Rights
30th Jun 20237:00 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.